| 1089283-49-7 Basic information More.. |
Product Name: | GSK1904529A | Synonyms: | GSK 4529;GSK1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A;GSK1904529A, >=98%;IGF-IR, IGF-IIR inhibitor | CAS: | 1089283-49-7 | MF: | C44H47F2N9O5S | MW: | 851.96 | EINECS: | | Mol File: | 1089283-49-7.mol | |
- GSK1904529A
-
- US $34.00-119.00 / mg
- 2024-11-19
- CAS:1089283-49-7
- Min. Order:
- Purity: 99%
- Supply Ability: 10g
- GSK1904529A
-
- US $1.10 / g
- 2024-04-17
- CAS:1089283-49-7
- Min. Order: 1g
- Purity: 99.0% min
- Supply Ability: 100 tons min
|
1089283-49-7
Recommend Suppliers |
|